# FDA Inspection 1217970 - Priyantha N. Wijewardane, M.D. - September 01, 2023

Source: https://www.keypedia.com/records/fda_inspections/priyantha-n-wijewardane-md/e47bd9b4-c4e0-4af3-9a8a-0b7f17d26af2
Source feed: FDA_Inspections

> FDA Inspection 1217970 for Priyantha N. Wijewardane, M.D. on September 01, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1217970
- Company Name: Priyantha N. Wijewardane, M.D.
- Inspection Date: 2023-09-01
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/priyantha-n-wijewardane-md/de3b4640-ae4c-4bb0-87e9-b1988b67ab0b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c